Breaking News

SCM Pharma Appoints Ops Director

May 21, 2013

Bradley brings extensive sterile manufacturing experience

Paul Bradley has been appointed operations director at SCM Pharma. He will also serve on the company’s board. Mr. Bradley will be responsible for all operational activities at SCM Pharma including production, warehouse and facilities. He joins the company from Hospira Aseptic Services and brings extensive experience in clinical trial and commercial manufacturing of sterile products.  
 
Dianne Sharp, managing director at SCM Pharma, said, “We are delighted to have Paul join the team as he brings a very distinct and important set of skills relating to operations to the management team.As the company continues to grow and handle more products, it’s vital we are reliably planning, manufacturing and delivering drugs to our clients whether they are for clinical trials or commercial market supply.Paul will no doubt be a great addition to the team and will play a significant role in overseeing and supporting client projects across both of our sites.”
  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks

  • The Growing Realm of Real-World Data

    Kristin Brooks, Contract Pharma||November 8, 2016
    PPD's Evidera acquisition aims to help clients address the growing demand for evidence from regulators and payers

  • Mastering Immunotherapy Clinical Trials: Dosing and Response

    Mastering Immunotherapy Clinical Trials: Dosing and Response

    Kristin Brooks, Contract Pharma||August 1, 2016
    Andrew Zupnick of Novella Clinical provides insights into dosing and measuring response in immunotherapy clinical trials

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research